Panbela Therapeutics ROIC
¿Qué es el ROIC de Panbela Therapeutics?
El ROIC de Panbela Therapeutics Inc. es -389.48%
¿Cuál es la definición de ROIC?
Return on invested capital (ROIC) is a financial ratio that measures how efficient a company is at allocating the capital under its control to profitable investments.
= NOPAT / Invested capital = EBIT * (1 - tax rate) / (2-year average liabilities + 2-year average shareholder equity)
Return on invested capital (ROIC) ratio gives investors a sense of how well a company is using money under its control to generate profitable returns.
ROIC can be used as a benchmark to calculate the valuation of companies across industries. A higher ROIC means the company is doing a better job of investing the money from shareholders and bondholders to run the business. A company is creating value if its ROIC exceeds 2%. If its ROIC is under 2%, the company is likely destroying value and has no excess capital to invest in future growth.
You can calculate ROIC with the following formula:
NOPAT = Net operating profit after tax
Invested Capital = Average total liabilities + Average shareholders' equity
The averages of liabilities and shareholders' equity are calculated as geometrical averages of the last two annual values from the company's balance sheet.
ROIC de compañías en Sector Health Care en NASDAQ en comparadas con Panbela Therapeutics
¿Qué hace Panbela Therapeutics?
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Empresas con roic similar a Panbela Therapeutics
- Trend Innovations tiene ROIC de -402.87%
- Killi tiene ROIC de -402.49%
- Loop Insights tiene ROIC de -399.47%
- Bald Eagle Gold tiene ROIC de -398.26%
- ProMIS Neurosciences tiene ROIC de -395.85%
- Gpo Plus Inc tiene ROIC de -393.16%
- Panbela Therapeutics tiene ROIC de -389.48%
- Cyclo3pss tiene ROIC de -381.50%
- Rebel Capital 2.0 tiene ROIC de -381.00%
- BioCorRx tiene ROIC de -378.47%
- Reliq Health Technologies tiene ROIC de -374.96%
- Roboserver Systems tiene ROIC de -374.21%
- Global Wellness Strategies tiene ROIC de -374.18%